Lumos Diagnostics Holdings Limited Annual Report 2026 Innovation at the point-of-care 2 L U M O S D I A G N O S T I C S 2 0 2 6 A N N U A L R E P O R T Lumos develops, manufactures and distributes world-leading diagnostic technologies - delivering actionable information, in real...
FY26 Annual Report
Filed with ASX ·
Watch Lumos Diagnostics' latest callLumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call · Replay · Apr 20Read the transcript of Lumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call6ix hasn’t read this filing yet.
Lumos Diagnostics Holdings Ltd. on 6ix
Story so far
Earlier from Lumos Diagnostics
- Lumos to Present at 20th Bioshares Biotech Summit
- Lumos Receives FebriDx Order from PHASE Scientific
- Lumos Secures Distribution for FebriDx in Romania
- Change of Director's Interest Notice - DW
- Section 708A Cleansing Statement
Later from Lumos Diagnostics
- FY26 Appendix 4E
- FY26 Full Year Results Announcement
- Appendix 4G and Corporate Governance Statement
- Application for quotation of securities - LDX
- FebriDx Commercial Traction Continues Across US Accounts
Follow Lumos Diagnostics into a list and get an email when it puts out news.
Follow Lumos Diagnostics